Related Experiment Video

Updated: Jul 4, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

Systems biology approaches to identify driver genes and drug combinations for treating COVID-19

Ali Ebrahimi1, Farinaz Roshani2

  • 1Department of Physics, Alzahra University, Tehran, Iran.

Scientific Reports
|January 26, 2024
PubMed

Insights

This study identifies key genes driving COVID-19 progression using network analysis. Findings reveal distinct gene expression patterns and suggest potential drug targets for better treatment strategies.

Area of Science:

  • * Virology and Bioinformatics
  • * Genomics and Systems Biology

Background:

  • * Coronavirus disease 2019 (COVID-19) presents significant global public health challenges.
  • * Despite extensive research and omics data, effective early diagnosis and comprehensive treatment remain elusive.
  • * Existing therapeutic strategies lack a deep understanding of the underlying molecular mechanisms driving disease progression.

Purpose of the Study:

  • * To identify critical hub and driver genes involved in COVID-19 pathogenesis.
  • * To analyze gene expression patterns and correlations in COVID-19 patients versus controls.
  • * To propose potential therapeutic interventions based on drug-gene interactions.

Main Methods:

  • * Network analysis of protein-protein interaction (PPI) networks and signaling pathways.
  • * Centrality and controllability analyses to identify key genes.
  • * Differential gene expression analysis and correlation pattern evaluation.
  • * Drug-gene interaction mapping to identify potential therapeutic agents.

Main Results:

  • * Identification of significant hub and driver genes crucial for COVID-19 development and progression.
  • * Demonstration of significant differential expression in key genes between COVID-19 patients and healthy controls.
  • * Observation of distinct gene expression correlation patterns indicative of disease state.
  • * Development of a bipartite graph illustrating drug-gene interactions for potential combination therapies.

Conclusions:

  • * The identified genes are critical players in COVID-19 pathogenesis.
  • * Distinct molecular signatures in gene expression and correlation patterns highlight disease mechanisms.
  • * The proposed drug-gene interactions offer a promising avenue for developing novel COVID-19 treatments.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.3K

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K